MetaCap

ADARx Pharmaceuticals Earnings

NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.79-1.37 (-9.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADARx Pharmaceuticals earnings summary

In its most recent report on Nov 12, 2026 (Sep/2026), ADRX posted EPS of $-1.74 versus the $-0.40 consensus estimate, a negative surprise of 335.0%.

Summary generated from market data by MetaCap's automated system. Methodology

ADRX earnings history

ADARx Pharmaceuticals reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 12, 2026$-0.40$-1.74-335.0%-9.9%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related